Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Nov 14, 2014

Total Value ($000): $274,672 (100.0% shares, 0.0% debt)

Holdings (10)

— REVANCE THERAPEUTICS INC 32.3%

Value ($000) $88,764 Shares 4,592,047 Est. Cost $31.50 Unrealized —

— ABIOMED INC 28.5%

Value ($000) $78,214 Shares 3,150,000 Est. Cost $21.56 Unrealized —

— CORIUM INTL INC 20.9%

Value ($000) $57,429 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENDOLOGIX INC 11.5%

Value ($000) $31,644 Shares 2,514,936 Est. Cost $18.00 Unrealized —

— ACURA PHARMACEUTICALS INC 2.8%

Value ($000) $7,629 Shares 10,284,886 Est. Cost $1.82 Unrealized —

— ZIOPHARM ONCOLOGY INC 2.6%

Value ($000) $7,130 Shares 2,764,908 Est. Cost $1.96 Unrealized —

MNOV MEDICINOVA INC 1.3%

Value ($000) $3,499 Shares 1,170,370 Est. Cost $2.95 Unrealized -22.6%

— CURIS INC 0.1%

Value ($000) $330 Shares 233,797 Est. Cost $3.19 Unrealized —

— PALATIN TECHNOLOGIES INC 0.0%

Value ($000) $23 Shares 23,928 Est. Cost $0.59 Unrealized —

— ECHO THERAPEUTICS INC 0.0%

Value ($000) $10 Shares 12,319 Est. Cost $2.52 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	REVANCE THERAPEUTICS INC	4,592,047	$88,764	32.3%	$31.50	—	COM	761330109
—	ABIOMED INC	3,150,000	$78,214	28.5%	$21.56	—	COM	003654100
—	CORIUM INTL INC	9,353,304	$57,429	20.9%	$7.77	—	COM	21887L107
—	ENDOLOGIX INC	2,514,936	$31,644	11.5%	$18.00	—	COM	29266S106
—	ACURA PHARMACEUTICALS INC	10,284,886	$7,629	2.8%	$1.82	—	COM NEW	00509L703
—	ZIOPHARM ONCOLOGY INC	2,764,908	$7,130	2.6%	$1.96	—	COM	98973P101
MNOV	MEDICINOVA INC	1,170,370	$3,499	1.3%	$2.95	-22.6%	COM NEW	58468P206
—	CURIS INC	233,797	$330	0.1%	$3.19	—	COM	231269101
—	PALATIN TECHNOLOGIES INC	23,928	$23	0.0%	$0.59	—	COM PAR $ .01	696077403
—	ECHO THERAPEUTICS INC	12,319	$10	0.0%	$2.52	—	COM NEW	27876L206